Insider Transactions in Q2 2022 at Vera Therapeutics, Inc. (VERA)
Insider Transaction List (Q2 2022)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Jun 22
2022
|
Joanne Curley Chief Development Officer |
SELL
Open market or private sale
|
Direct |
1,545
-3.09%
|
$23,175
$15.02 P/Share
|
|
Jun 22
2022
|
Joanne Curley Chief Development Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
1,239
+4.68%
|
$7,434
$6.37 P/Share
|
|
Jun 17
2022
|
Joanne Curley Chief Development Officer |
SELL
Open market or private sale
|
Direct |
5,887
-7.18%
|
$88,305
$15.05 P/Share
|
|
Jun 17
2022
|
Joanne Curley Chief Development Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
4,687
+7.65%
|
$18,748
$4.64 P/Share
|
|
Jun 15
2022
|
Sean Grant CHIEF FINANCIAL OFFICER |
BUY
Open market or private purchase
|
Indirect |
5,000
+50.0%
|
$65,000
$13.6 P/Share
|
|
May 31
2022
|
Joanne Curley Chief Development Officer |
SELL
Open market or private sale
|
Direct |
400
-1.56%
|
$6,000
$15.22 P/Share
|
|
May 31
2022
|
Joanne Curley Chief Development Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
400
+1.54%
|
$2,400
$6.37 P/Share
|